Corporate Information And Statement Of Ifrs Compliance [Abstract]

ABIONYX Pharma - Filing #2813091

Concept	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2021-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification	ABIONYX PHARMA	—	—
Domicile of entity	Balma	—	—
Legal form of entity	société anonyme	—	—
Country of incorporation	France	—	—
Address of entity's registered office	33-43, avenue Georges Pompidou, Bât D – 31130 Balma	—	—
Principal place of business	France	—	—
Description of nature of entity's operations and principal activities	ABIONYX Pharma est une société biotech de nouvelle génération dédiée à la découverte et au développement de thérapies innovantes visant à améliorer la vie des patients.	—	—
Statement of IFRS compliance [text block]	ii. Conformité au référentiel IFRS	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]	—	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current inventories	—	147,000 EUR	177,000 EUR